Clinical Trial Update: 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) [Phase 2]

View source ↗

Summary

Phase 2 extension study assessing the effect of teriparatide on bone in people with chronic spinal cord injury has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss
• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Northwestern University | Conditions: Spinal Cord Injury, Bone Loss | Phase 2 | Status: COMPLETED | Results posted: 2018-09-25